Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | GSK3B | P49841 | 3/20 | 0.50 |
| ▸ | RECQL | P46063 | 1/20 | 0.50 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.50 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | PKM | P14618 | 3/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA2 | P00918 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.47 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | PRMT1 | Q99873 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL846835 | 0.87 | GSK3B (0.64) | GAAKMT2AGSK3BLMNAPKM | |
| SCHEMBL7311605 | 0.79 | GAA (0.64) | GAAKMT2ALMNAPKMALDH1A1 | |
| SCHEMBL10831304 | 0.79 | GSR (0.59) | KMT2AGSK3BALDH1A1HIF1ATRPA1 | |
| SCHEMBL7316384 | 0.77 | ALDH1A1 (0.71) | GAAKMT2ARECQLPKMALDH1A1 | |
| SCHEMBL3773485 | 0.77 | GAA (0.67) | GAAKMT2ALMNAPKMALDH1A1 | |
| SCHEMBL10476894 | 0.76 | GAA (0.80) | GAAKMT2APKMALDH1A1CA12 | |
| SCHEMBL3890773 | 0.76 | MMP2 (0.45) | GAAKMT2ARECQLHSD11B1CA1 | |
| SCHEMBL10067072 | 0.76 | GAA (1.00) | GAAKMT2ALMNAPKMALDH1A1 | |
| SCHEMBL11480265 | 0.76 | GSK3B (0.80) | KMT2AGSK3BALDH1A1HIF1ATRPA1 | |
| SCHEMBL4400955 | 0.76 | GAA (1.00) | GAAKMT2ALMNAPKMALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10307505-B2 | Wound dressings for the controlled release of therapeutic agents | KCI USA, INC. (US) | 2019-06-04 | — | — | US | claimed |
| US-20170333592-A1 | Wound Dressings For The Controlled Release Of Therapeutic Agents | SYSTAGENIX WOUND MANAGEMENT, LIMITED (GB) | 2017-11-23 | — | — | US | claimed |
| US-9687581-B2 | Wound dressings for the controlled release of therapeutic agents | KCI USA, INC. (US) | 2017-06-27 | — | — | US | claimed |
| US-20150098985-A1 | WOUND DRESSINGS FOR THE CONTROLLED RELEASE OF THERAPEUTIC | KCI USA, INC. | 2015-04-09 | — | — | US | claimed |
| US-8858987-B2 | Wound dressing for the controlled release of therapeutic agents | SYSTAGENIX WOUND MANAGEMENT (US), INC. (US) | 2014-10-14 | — | — | US | claimed |
| EP-1687039-B1 | WOUND DRESSINGS FOR THE CONTROLLED RELEASE OF THERAPEUTIC AGENTS | ETHICON INC (US) | 2009-01-28 | — | — | EP | claimed |
| US-20070148214-A1 | Wound dressing for the controlled release of therapeutic agents | KCI USA, INC. | 2007-06-28 | — | — | US | claimed |
| EP-1687039-A1 | WOUND DRESSINGS FOR THE CONTROLLED RELEASE OF THERAPEUTIC AGENTS | ETHICON, INC. (US) | 2006-08-09 | — | — | EP | claimed |
| WO-2005051441-A1 | WOUND DRESSINGS FOR THE CONTROLLED RELEASE OF THERAPEUTIC AGENTS | ETHICON, INC. (US) | 2005-06-09 | — | — | WO | claimed |
| US-20200221753-A1 | TEXTURED INGESTIBLE PRODUCTS | EETBE INC (US) | 2020-07-16 | — | — | US | disclosed |
| US-10307505-B2 | Wound dressings for the controlled release of therapeutic agents | KCI USA, INC. (US) | 2019-06-04 | — | — | US | disclosed |
| US-20170333592-A1 | Wound Dressings For The Controlled Release Of Therapeutic Agents | SYSTAGENIX WOUND MANAGEMENT, LIMITED (GB) | 2017-11-23 | — | — | US | disclosed |
| US-20170196253-A1 | TEXTURED INGESTIBLE PRODUCTS | EETBE, INC. | 2017-07-13 | — | — | US | disclosed |
| US-9687581-B2 | Wound dressings for the controlled release of therapeutic agents | KCI USA, INC. (US) | 2017-06-27 | — | — | US | disclosed |
| WO-2004041179-A2 | SCAVENGER RECEPTOR B1 (CLA-1) TARGETING FOR THE TREATMENT OF INFECTION, SEPSIS AND INFLAMMATION | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF HEALTH AND HUMAN SERVICES, NIH (US) | 2004-05-21 | — | — | WO | disclosed |
| US-6573094-B1 | Identification of components of E3 complex involved in ubiquitination of cell cycle regulator proteins, including a class of proteins that directly function in recognition of ubiquitination targets; use for drug discovery and assessment | BAYLOR COLLEGE OF MEDICINE | 2003-06-03 | — | — | US | disclosed |
| WO-2000063350-A9 | CYSTEINE PROTEASE AND INHIBITORS FOR PREVENTION AND TREATMENT OF NEUROCYSTICEROCOSIS | UNIV GEORGIA RES FOUND (US) | 2002-06-13 | — | — | WO | disclosed |
| US-6232081-B1 | COMPLEXING WITH SLIMB PROTEIN | BAYLOR COLLEGE OF MEDICINE | 2001-05-15 | — | — | US | disclosed |
| WO-2000063350-A2 | CYSTEINE PROTEASE AND INHIBITORS FOR PREVENTION AND TREATMENT OF NEUROCYSTICEROCOSIS | THE UNIVERSITY OF GEORGIA RESEARCH FOUNDATION, INC. (US) | 2000-10-26 | — | — | WO | disclosed |
| US-5328844-A | Amino acid nutrients | UNIVERSITY OF COLORADO FOUNDATION, INC. (US) | 1994-07-12 | — | — | US | disclosed |